The Healthcare and Pharmaceuticals industry in India is on an 8 word high!
Yes even as you read this report, more informed Patients, technology savvy HCP’s and digitally empowered Medical Representatives are Evolving!
In the age of quantified self, Indian patients and HCPs are exhibiting an expectations market, and with the advent of digital health, big data and dialogue exchange; Indian pharmaceuticals cannot afford to stay behind the curve.
India has recently evolved as one of the biggest and fastest digital consumer base in the world, and healthcare is one of the top search topics across geographies.
With The Indian Pharma Digital Health Report 2015, we have strived to map out the ‘Digital Health’ of Pharmaceuticals Industry, help them identify the loopholes, design a roadmap and help them incorporate digital medium in part of the decision making process.
We have surveyed performance over a period of 2 weeks (22nd May-5th June2015) across 10 key parameter of:
Social Media platforms
Basis the ranking the companies have been segregated in key buckets of Digital Primes, Aspirants and Onlookers.
We have found 9 Digital Primes, 18 Aspirants and 13 Onlookers.
What has emerged as a pattern in the report findings is; “Presence Vs Engagement”, i.e while pharmaceutical companies in India are present or registered on most social media platforms, they are holding back on actively engaging with stakeholders.
While the consumer market of patients and HCPs is ready for embracing an inflow of information from the healthcare and pharmaceutical players, the companies are still reluctant to use the digital platforms proactively.
Unlike other industries, pharma has been a late entrant to reap the benefits of the digital space but over the past few years, some of the pharma companies are making conscious effort to work towards comprehensive patient care and are up on the ladder to become a patient centric entity rather than a molecule promoting arm.
Pharmaceutical companies are now actively participating in building engaging relationship with the brand or spreading product/disease awareness communication and we strongly believe that a well crafted and a smart communication strategy aimed at engaging consumers and other healthcare stakeholders, within the regulatory framework ultimately enhances brand and company reputation.
As responsible pharma communicators, it is our duty to drive the industries digital engagements and that’s why here we come with a succinct summary of our learning about digital media in the pharmaceutical sector. These are the key takeaways that can serve as a guide to pharma companies going digital!